Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

2.91
Delayed Data
As of Aug 18
 +0.01 / +0.34%
Today’s Change
2.85
Today|||52-Week Range
7.15
-52.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues0.000.0098.0K2.3M
 
 
 
Cost of Goods Sold0.000.001.8M2.9M
 
 
 
Depreciation And Amortization114.0K40.0K41.0K39.0K
 
 
 
 
 
 
Operating ExpensesGross Income-114.0K-40.0K-1.7M-576.0K
 
 
 
 
 
General Expenses38.4M42.4M61.0M73.0M
 
 
 
 
 
Research And Development24.6M17.2M19.1M22.3M
 
 
 
 
 
Total Operating Expenses38.5M42.4M62.8M75.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-38.5M-42.4M-62.7M-73.6M
 
 
 
 
 
Extraordinary Credit0.000.00122.0K39.0K
 
 
 
Extraordinary Charge-87.0K-14.6M-1.2M0.00
 
 
 
 
Interest Expense On Debt1.7M3.0M790.0K345.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-40.2M-60.0M-64.6M-73.9M
 
 
 
 
 
Income Taxes0.00-126.0K0.000.00
 
 
Net Income-40.2M-59.9M-64.6M-73.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS179.8M190.1M215.5M224.9M
 
 
 
 
 
Shares To Calculate EPS Diluted179.8M190.1M215.5M224.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22-$0.31-$0.30-$0.33
 
 
 
 
 
EPS Diluted-$0.22-$0.31-$0.30-$0.33